Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis

le Ramirez-Ardila, Diana, Timmermans, A. Mieke, Helmijr, Jean A., Martens, John W.M., Berns, Els M.J.J., Jansen, Maurice P.H.M.
Foilsithe in Transl Oncol (2017)

Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma

le Ge, Zhouhong, Helmijr, Jean C.A., Jansen, Maurice P.H.M., Boor, Patrick P.C., Noordam, Lisanne, Peppelenbosch, Maikel, Kwekkeboom, Jaap, Kraan, Jaco, Sprengers, Dave
Foilsithe in Transl Oncol (2021)

LRG1 mRNA expression in breast cancer associates with PIK3CA genotype and with aromatase inhibitor therapy outcome

le Ramirez-Ardila, Diana E., Ruigrok-Ritstier, Kirsten, Helmijr, Jean C., Look, Maxime P., van Laere, Steven, Dirix, Luc, Berns, Els M.J.J., Jansen, Maurice P.H.M.
Foilsithe in Mol Oncol (2016)

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane

le Kruger, Dinja T., Jansen, Maurice P.H.M., Konings, Inge R.H.M., Dercksen, Wouter M., Jager, Agnes, Oulad Hadj, Jamal, Sleijfer, Stefan, Martens, John W.M., Boven, Epie
Foilsithe in Mol Oncol (2020)

Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of co...

le Beije, Nick, Helmijr, Jean C., Weerts, Marjolein J.A., Beaufort, Corine M., Wiggin, Matthew, Marziali, Andre, Verhoef, Cornelis, Sleijfer, Stefan, Jansen, Maurice P.H.M., Martens, John W.M.
Foilsithe in Mol Oncol (2016)

Application of circulating tumor DNA in prospective clinical oncology trials – standardization of preanalytical conditions

le van Dessel, Lisanne F., Beije, Nick, Helmijr, Jean C.A., Vitale, Silvia R., Kraan, Jaco, Look, Maxime P., de Wit, Ronald, Sleijfer, Stefan, Jansen, Maurice P.H.M., Martens, John W.M., Lolkema, Martijn P.
Foilsithe in Mol Oncol (2017)

High‐throughput isolation of circulating tumor DNA: a comparison of automated platforms

le van Dessel, Lisanne F., Vitale, Silvia R., Helmijr, Jean C. A., Wilting, Saskia M., van der Vlugt‐Daane, Michelle, Oomen‐de Hoop, Esther, Sleijfer, Stefan, Martens, John W. M., Jansen, Maurice P. H. M., Lolkema, Martijn P.
Foilsithe in Mol Oncol (2018)

Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNA

le Weerts, Marjolein J. A., van Marion, Ronald, Helmijr, Jean C. A., Beaufort, Corine M., Krol, Niels M. G., Trapman-Jansen, Anita M. A. C., Dinjens, Winand N. M., Sleijfer, Stefan, Jansen, Maurice P. H. M., Martens, John W. M.
Foilsithe in Sci Rep (2017)

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA

le Bos, Manouk K., Nasserinejad, Kazem, Jansen, Maurice P. H. M., Angus, Lindsay, Atmodimedjo, Peggy N., de Jonge, Evert, Dinjens, Winand N. M., van Schaik, Ron H. N., Del Re, Marzia, Dubbink, Hendrikus J., Sleijfer, Stefan, Martens, John W. M.
Foilsithe in Mol Oncol (2020)

TP53 Mutations in Serum Circulating Cell-Free Tumor DNA As Longitudinal Biomarker for High-Grade Serous Ovarian Cancer

le Vitale, Silvia R., Groenendijk, Floris H., van Marion, Ronald, Beaufort, Corine M., Helmijr, Jean C., Jan Dubbink, Hendrikus, N. M. Dinjens, Winand, Ewing-Graham, Patricia C., Smolders, Ramon, van Doorn, Helena C., Boere, Ingrid A., Berns, Els M. J. J., Helleman, Jozien, Jansen, Maurice P. H. M.
Foilsithe in Biomolecules (2020)

Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer

le Vitale, Silvia R., Helmijr, Jean A., Gerritsen, Marjolein, Coban, Hicret, van Dessel, Lisanne F., Beije, Nick, van der Vlugt-Daane, Michelle, Vigneri, Paolo, Sieuwerts, Anieta M., Dits, Natasja, van Royen, Martin E., Jenster, Guido, Sleijfer, Stefan, Lolkema, Martijn, Martens, John W. M., Jansen, Maurice P. H. M.
Foilsithe in BMC Cancer (2021)

Optimizing Nanopore sequencing-based detection of structural variants enables individualized circulating tumor DNA-based disease monitoring in cancer patients

le Valle-Inclan, Jose Espejo, Stangl, Christina, de Jong, Anouk C., van Dessel, Lisanne F., van Roosmalen, Markus J., Helmijr, Jean C. A., Renkens, Ivo, Janssen, Roel, de Blank, Sam, de Witte, Chris J., Martens, John W. M., Jansen, Maurice P. H. M., Lolkema, Martijn P., Kloosterman, Wigard P.
Foilsithe in Genome Med (2021)

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients

le Beije, Nick, Sieuwerts, Anieta M., Kraan, Jaco, Van, Ngoc M., Onstenk, Wendy, Vitale, Silvia R., van der Vlugt‐Daane, Michelle, Dirix, Luc Y., Brouwer, Anja, Hamberg, Paul, de Jongh, Felix E., Jager, Agnes, Seynaeve, Caroline M., Jansen, Maurice P. H. M., Foekens, John A., Martens, John W. M., Sleijfer, Stefan
Foilsithe in Mol Oncol (2017)

RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer

le van Helden, Erik J., Angus, Lindsay, Menke‐van der Houven van Oordt, C. Willemien, Heideman, Daniëlle A. M., Boon, Eline, van Es, Suzanne C., Radema, Sandra A., van Herpen, Carla M. L., de Groot, Derk Jan A., de Vries, Elisabeth G. E., Jansen, Maurice P. H. M., Sleijfer, Stefan, Verheul, Henk M. W.
Foilsithe in Mol Oncol (2019)

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

le Reijm, Esther A., Sieuwerts, Anieta M., Smid, Marcel, Vries, Joan Bolt-de, Mostert, Bianca, Onstenk, Wendy, Peeters, Dieter, Dirix, Luc Y., Seynaeve, Caroline M., Jager, Agnes, de Jongh, Felix E., Hamberg, Paul, van Galen, Anne, Kraan, Jaco, Jansen, Maurice P. H. M., Gratama, Jan W., Foekens, John A., Martens, John W. M., Berns, Els M. J. J., Sleijfer, Stefan
Foilsithe in BMC Cancer (2016)

Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen

le Jansen, Maurice P.H.M., Martens, John W.M., Helmijr, Jean C.A., Beaufort, Corine M., van Marion, Ronald, Krol, Niels M.G., Monkhorst, Kim, Trapman-Jansen, Anita M.A.C., Meijer-van Gelder, Marion E., Weerts, Marjolein J.A., Ramirez-Ardila, Diana E., Jan Dubbink, Hendrikus, Foekens, John A., Sleijfer, Stefan, Berns, Els M.J.J.
Foilsithe in Oncotarget (2016)

Decreased expression of ABAT and STC2 hallmarks ER‐positive inflammatory breast cancer and endocrine therapy resistance in advanced disease

le Jansen, Maurice P.H.M., Sas, Leen, Sieuwerts, Anieta M., Van Cauwenberghe, Caroline, Ramirez-Ardila, Diana, Look, Maxime, Ruigrok-Ritstier, Kirsten, Finetti, Pascal, Bertucci, François, Timmermans, Mieke M., van Deurzen, Carolien H.M., Martens, John W.M., Simon, Iris, Roepman, Paul, Linn, Sabine C., van Dam, Peter, Kok, Marleen, Lardon, Filip, Vermeulen, Peter B., Foekens, John A., Dirix, Luc, Berns, Els M.J.J., Van Laere, Steven
Foilsithe in Mol Oncol (2015)